Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery of widespread tumour growth gene holds promise for effective anti-cancer treatment

24.09.2007
Italian scientists will announce today (Monday September 24) that they have found a new and promising target for anti-tumour therapy in cancer.

Professor Saverio Alberti, from the CESI, University of Chieti Foundation, Chieti, will tell the European Cancer Conference (ECCO 14) that he and his team have found a widespread mechanism for the stimulation of tumour growth in man, and that this is leading to the development of novel diagnostic and therapeutic procedures.

Professor Alberti and his team have discovered the function of the Trop-2 gene, a product of the TACTD2 gene, which is expressed in placenta, an ‘invasive’ normal tissue. “The function of Trop-2 was a mystery until now,” says Professor Alberti, “but knowing its expression in the trophoblast (cells forming the outer layer of the blastocyst – the stage between the fertilised egg and the embryo) during pregnancy, we thought that it might well be involved in another invasive function – tumour growth.”

The scientists analysed the genes in human tumours and found that Trop-2 was expressed in the vast majority of human cancers, for example, breast, colon, stomach, lung, prostate, ovary, endometrium, uterine cervix and pancreas. Over-expression of the Trop-2 gene was also found when immunohistochemical (IHC) analysis of 1,755 tumours was undertaken. IHC analysis looks at the interaction of antibodies and antigens in tissues, and has the advantage of showing exactly where in a tissue a given protein is located. “This has allowed us to develop anti-Trop-2 monoclonal antibodies for immunotherapy (modulation of the immune system to reject and destroy tumours) of Trop-2 expressing tumours,” explains Professor Alberti.

... more about:
»Trop-2 »found »metastases

Trop-2 over-expression was found in between 65% and 90% of the tumour types analysed, with an average of 74% across the board. “These figures are high,” explains Professor Alberti. “In comparison, telomerase over-expression, possibly the most fundamental mechanism for cell immortalisation, is observed in 80% of all tumours. Telomerase is an enzyme that adds specific DNA repeats to the ends of chromosomes, so not strictly comparable. When we come to look at genes, her2/neu is a key determinant of breast cancer aggressiveness and is over-expressed in 25% of the cancers, and amplified in only a subgroup of them; and p53, possibly the most fundamental of tumour suppressors, is mutated and/or over-expressed in 50% of tumours. Mutations of the epidermal growth factor receptor gene (EGFR) are relatively infrequent in most cancers, reach 30% of the non small-cell lung cancers and are present at frequencies of around 75% in only a small subgroup of the latter. Most other markers known to date show lower figures and/or can be detected at high frequency in only a subgroup of tumours, for example PSA in prostate cancer. So Trop-2 really stands out.”

“It is also a unique marker of cancer metastases in different tumour types – including colon, stomach, breast, and ovary in man – and across a number of species,” he says. In man, most metastases in lymph nodes or down-stream organs, for example liver in colon cancer, express higher levels of Trop-2 compared with the primary tumours. Trop-2 induces these metastases through mechanisms that the scientists are beginning to unravel. The most intriguing of these findings, they say, is the presence of two sequence elements in the Trop-2 cytoplasmic tail, the signalling engine of Trop-2, which act as, respectively, an enhancer and a silencer of metastatic propensity. This may be the key to the identification of signalling molecules that promote or inhibit the formation of metastases.

“If we can identify such molecules we will be approaching a situation where we could influence their activity and hence either encourage or prevent it,” says Professor Alberti. “This could be an important step towards stopping cancer in its tracks.”

In addition, the scientists want to extend their knowledge of the cell changes induced by receptor activation, or signal transduction pathways, triggered by Trop-2. “This will be crucial for the better understanding of the way in which tumour growth is regulated by the gene, and will also provide additional targets for anti-cancer drugs,” says Professor Alberti. “We are very excited about the prospects for therapy which we can see arising from this discovery.”

Mary Rice | alfa
Further information:
http://www.fecs.be

Further reports about: Trop-2 found metastases

More articles from Life Sciences:

nachricht New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences

nachricht The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>